Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
16,681,212
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
4,662,591
-
Shares change
-
+218,011
-
Total reported value, excl. options
-
$30,167,676
-
Value change
-
+$1,480,613
-
Number of buys
-
15
-
Number of sells
-
-9
-
Price
-
$6.47
Significant Holders of Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA) as of Q1 2025
31 filings reported holding COYA - Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2025.
Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,662,591 shares
of 16,681,212 outstanding shares and own 27.95% of the company stock.
Largest 10 shareholders include DME Capital Management, LP (1,646,440 shares), AIGH Capital Management LLC (1,183,780 shares), VANGUARD GROUP INC (840,471 shares), CM Management, LLC (200,000 shares), Dauntless Investment Group, LLC (167,378 shares), GEODE CAPITAL MANAGEMENT, LLC (155,829 shares), BlackRock, Inc. (83,795 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (58,982 shares), STATE STREET CORP (48,100 shares), and PRELUDE CAPITAL MANAGEMENT, LLC (35,770 shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.